Balaxi Pharmaceuticals reports revenue of INR 1,124 million in H1FY21
HYDERABAD, India, Oct. 12, 2020 -- Balaxi Pharmaceuticals Limited (BPL), a branded IPR-based pharmaceutical company, today announced its results for ...
Read moreHYDERABAD, India, Oct. 12, 2020 -- Balaxi Pharmaceuticals Limited (BPL), a branded IPR-based pharmaceutical company, today announced its results for ...
Read more© 2018 | Fortune World Media | MEDIA & ENTERTAINMENT CO. IN | Powered by Raja's Digital
© 2018 | Fortune World Media | MEDIA & ENTERTAINMENT CO. IN | Powered by Raja's Digital